Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Recursion Pharmaceuticals is a US-based biotechnology company revolutionizing drug discovery with artificial intelligence (AI) and machine learning. By analyzing vast biological datasets, the company accelerates the identification of novel therapeutics for complex diseases, driving the future of precision medicine.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Recursion Pharmaceuticals is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Recursion Pharmaceuticals last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at -0.25 USD.
Across its last 3 earnings reports, Recursion Pharmaceuticals stock moved by ±3.1% on average the following day. The largest reaction was +6.8% on 02/25/2026; 2 of 3 reactions were positive.
Recursion Pharmaceuticals has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.